annual operating expenses:
$604.63M+$158.89M(+35.65%)Summary
- As of today (September 10, 2025), ARWR annual total operating expenses is $604.63 million, with the most recent change of +$158.89 million (+35.65%) on September 30, 2024.
- During the last 3 years, ARWR annual operating expenses has risen by +$317.31 million (+110.44%).
- ARWR annual operating expenses is now at all-time high.
Performance
ARWR Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$187.09M+$31.67M(+20.38%)Summary
- As of today (September 10, 2025), ARWR quarterly total operating expenses is $187.09 million, with the most recent change of +$31.67 million (+20.38%) on June 30, 2025.
- Over the past year, ARWR quarterly operating expenses has increased by +$15.73 million (+9.18%).
- ARWR quarterly operating expenses is now at all-time high.
Performance
ARWR quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ARWR Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.6% | +9.2% |
| 3 y3 years | +110.4% | +82.1% |
| 5 y5 years | +461.9% | +1073.3% |
ARWR Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.4% | at high | +96.0% |
| 5 y | 5-year | at high | +461.9% | at high | +1073.3% |
| alltime | all time | at high | >+9999.0% | at high | +950.0% |
ARWR Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $187.09M(+20.4%) |
| Mar 2025 | - | $155.42M(-2.1%) |
| Dec 2024 | - | $158.68M(+1.0%) |
| Sep 2024 | $604.63M(+35.6%) | $157.18M(-8.3%) |
| Jun 2024 | - | $171.36M(+40.8%) |
| Mar 2024 | - | $121.67M(-10.4%) |
| Dec 2023 | - | $135.83M(+12.7%) |
| Sep 2023 | $445.74M(+5.7%) | $120.57M(+4.6%) |
| Jun 2023 | - | $115.25M(+20.8%) |
| Mar 2023 | - | $95.43M(-6.4%) |
| Dec 2022 | - | $101.99M(-9.5%) |
| Sep 2022 | $421.74M(+46.8%) | $112.75M(+9.8%) |
| Jun 2022 | - | $102.72M(-4.6%) |
| Mar 2022 | - | $107.67M(+22.1%) |
| Dec 2021 | - | $88.19M(+35.9%) |
| Sep 2021 | $287.32M(+58.6%) | $64.88M(+103.6%) |
| Jun 2021 | - | $31.87M(+12.9%) |
| Mar 2021 | - | $28.23M(+17.4%) |
| Dec 2020 | - | $24.05M(-52.0%) |
| Sep 2020 | $181.15M(+68.3%) | $50.12M(+214.3%) |
| Jun 2020 | - | $15.95M(-28.3%) |
| Mar 2020 | - | $22.24M(+358.2%) |
| Dec 2019 | - | $4.85M(-150.4%) |
| Sep 2019 | $107.61M(+49.3%) | -$9.64M(-48.2%) |
| Jun 2019 | - | -$18.60M(-15.5%) |
| Mar 2019 | - | -$22.01M(+101.1%) |
| Dec 2018 | - | -$10.95M(-198.0%) |
| Sep 2018 | $72.08M(+5.4%) | $11.17M(-29.8%) |
| Jun 2018 | - | $15.92M(+5.9%) |
| Mar 2018 | - | $15.03M(+8.8%) |
| Dec 2017 | - | $13.81M(+34.8%) |
| Sep 2017 | $68.40M(-14.3%) | $10.25M(+79.4%) |
| Jun 2017 | - | $5.71M(-6.8%) |
| Mar 2017 | - | $6.13M(-58.9%) |
| Dec 2016 | - | $14.90M(-41.8%) |
| Sep 2016 | $79.85M(-17.1%) | $25.61M(+32.4%) |
| Jun 2016 | - | $19.34M(-9.0%) |
| Mar 2016 | - | $21.26M(+9.9%) |
| Dec 2015 | - | $19.34M(-17.1%) |
| Sep 2015 | $96.36M(+87.9%) | $23.34M(+45.9%) |
| Jun 2015 | - | $15.99M(-17.9%) |
| Mar 2015 | - | $19.49M(-22.4%) |
| Dec 2014 | - | $25.12M(+41.0%) |
| Sep 2014 | $51.28M(+117.5%) | $17.81M(+40.2%) |
| Jun 2014 | - | $12.70M(+13.3%) |
| Mar 2014 | - | $11.21M(+60.0%) |
| Dec 2013 | - | $7.01M(+6.6%) |
| Sep 2013 | $23.57M(+11.0%) | $6.58M(+29.4%) |
| Jun 2013 | - | $5.08M(-5.7%) |
| Mar 2013 | - | $5.39M(+12.1%) |
| Dec 2012 | - | $4.81M(-3.3%) |
| Sep 2012 | $21.24M | $4.98M(+4.2%) |
| Jun 2012 | - | $4.77M(-2.0%) |
| Mar 2012 | - | $4.87M(+37.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $3.54M(+24.2%) |
| Sep 2011 | $10.13M(+73.6%) | $2.85M(+67.2%) |
| Jun 2011 | - | $1.70M(+76.8%) |
| Mar 2011 | - | $963.50K(-80.1%) |
| Dec 2010 | - | $4.84M(+298.2%) |
| Sep 2010 | $5.83M(-75.0%) | $1.22M(-6.8%) |
| Jun 2010 | - | $1.30M(-38.7%) |
| Mar 2010 | - | $2.13M(+89.2%) |
| Dec 2009 | - | $1.13M(-58.3%) |
| Sep 2009 | $23.32M(-35.8%) | $2.70M(+16.1%) |
| Jun 2009 | - | $2.32M(-32.0%) |
| Mar 2009 | - | $3.42M(-35.2%) |
| Dec 2008 | - | $5.27M(-32.9%) |
| Sep 2008 | $36.31M(-5.5%) | $7.87M(-18.9%) |
| Jun 2008 | - | $9.70M(+145.1%) |
| Mar 2008 | - | $3.96M(-42.7%) |
| Dec 2007 | - | $6.91M(-16.0%) |
| Sep 2007 | $38.43M(+82.3%) | $8.23M(-23.6%) |
| Jun 2007 | - | $10.77M(+70.5%) |
| Mar 2007 | - | $6.31M(+128.9%) |
| Dec 2006 | - | $2.76M(-64.5%) |
| Sep 2006 | $21.08M(+107.0%) | $7.76M(+188.2%) |
| Jun 2006 | - | $2.69M(+6.0%) |
| Mar 2006 | - | $2.54M(-13.6%) |
| Dec 2005 | - | $2.94M(+124.0%) |
| Sep 2005 | $10.18M(+252.7%) | $1.31M(-48.4%) |
| Jun 2005 | - | $2.54M(+97.2%) |
| Mar 2005 | - | $1.29M(-33.7%) |
| Dec 2004 | - | $1.94M(+29.8%) |
| Sep 2004 | $2.89M(+2958.4%) | $1.50M(+151.4%) |
| Jun 2004 | - | $596.00K(+17.7%) |
| Mar 2004 | - | $506.50K(+297.3%) |
| Dec 2003 | - | $127.50K(+624.4%) |
| Sep 2003 | $94.40K(-93.3%) | $17.60K(+16.6%) |
| Jun 2003 | - | $15.10K(-47.2%) |
| Mar 2003 | - | $28.60K(-10.9%) |
| Dec 2002 | - | $32.10K(-27.2%) |
| Sep 2002 | $1.42M(+1197.7%) | - |
| Jun 2002 | - | $44.10K(+92.6%) |
| Mar 2002 | - | $22.90K(-15.2%) |
| Dec 2001 | - | $27.00K(+44.4%) |
| Sep 2001 | $109.30K(-17.2%) | - |
| Jun 2001 | - | $18.70K(-21.8%) |
| Mar 2001 | - | $23.90K(-37.1%) |
| Dec 2000 | - | $38.00K(+37.2%) |
| Sep 2000 | $132.00K(+46.0%) | $27.70K(+7.8%) |
| Jun 2000 | - | $25.70K(-13.8%) |
| Mar 2000 | - | $29.80K(-16.3%) |
| Dec 1999 | - | $35.60K(+1680.0%) |
| Sep 1999 | $90.40K(+15.9%) | $2000.00(-89.7%) |
| Jun 1999 | - | $19.40K(+14.8%) |
| Mar 1999 | - | $16.90K |
| Sep 1998 | $78.00K(-60.6%) | - |
| Sep 1997 | $198.20K | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual operating expenses year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual total operating expenses?
The current annual operating expenses of ARWR is $604.63M
What is the all time high annual operating expenses for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual total operating expenses is $604.63M
What is Arrowhead Pharmaceuticals, Inc. annual operating expenses year-on-year change?
Over the past year, ARWR annual total operating expenses has changed by +$158.89M (+35.65%)
What is Arrowhead Pharmaceuticals, Inc. quarterly total operating expenses?
The current quarterly operating expenses of ARWR is $187.09M
What is the all time high quarterly operating expenses for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $187.09M
What is Arrowhead Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
Over the past year, ARWR quarterly total operating expenses has changed by +$15.73M (+9.18%)